(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.89% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.
Envista Holdings's revenue in 2024 is $2,566,500,000.On average, 7 Wall Street analysts forecast NVST's revenue for 2024 to be $446,764,918,261, with the lowest NVST revenue forecast at $444,932,419,762, and the highest NVST revenue forecast at $450,456,333,980. On average, 7 Wall Street analysts forecast NVST's revenue for 2025 to be $467,594,363,617, with the lowest NVST revenue forecast at $460,028,831,290, and the highest NVST revenue forecast at $481,191,255,450.
In 2026, NVST is forecast to generate $497,447,345,863 in revenue, with the lowest revenue forecast at $481,815,697,927 and the highest revenue forecast at $513,078,993,800.